Niche Rehab Focus Ampcare sells an FDA 510k cleared swallowing rehabilitation protocol combining electrical stimulation, posture strategies, and exercise for speech pathologists, indicating a specialized, clinical market with access via medical device channels.

Small team, target With a lean headcount and a clear clinical offering, there is potential to scale through strategic partnerships, distributors, and contract sales to clinics, hospitals, and private practices specializing in dysphagia.

Clinical Differentiator ESP combines technology and therapy protocols, which can be positioned against generic rehab devices by emphasizing FDA clearance, integrated protocol, and measurable swallowing outcomes to drive adoption.

Growth levers Revenue under 1M suggests opportunities in expanding clinic networks, training programs for SLPs,ari adding recurring revenue via service agreements, and upsell to adjacent dysphagia care products.

Tech & Reach Current tech stack indicates strong digital presence and marketing capabilities; leveraging AWS, WordPress, and eCommerce platforms can support lead generation, onboarding, and cross-sell to therapy providers.